Premier Graphene (BIEI) 10-Q2018 Q1 Quarterly report

Filed: 23 May 18, 11:55am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: April, commercial, criteria, customer, delivery, denominator, EPS, excluded, fee, goal, meet, numerator, obligation, obtain, persuasive, pilot, pursue, push, reduction, restricted, service, support, treasury, twelve, ultimately

Removed: acceptable, accounted, accredited, advanced, allocated, anniversary, appointed, arise, assist, beneficial, Borza, California, cancel, candidate, caption, charge, Clarifying, closed, closing, collectively, comparing, connection, considerable, consolidated, consolidation, continuously, controlling, corner, corporate, correct, covering, credit, Diego, Dr, drew, duration, earlier, equal, exceeded, exempt, faithful, familiar, feature, Feldetrex, file, Founder, funding, goodwill, growing, guaranteed, Hartman, hereof, ii, iii, impairment, independently, influence, investee, John, labor, LaBorde, lack, launched, leukemia, lieu, listed, loan, lower, managed, manufacture, medical, member, noncontrolling, Notice, offering, originated, parent, partial, partnered, patience, Patricio, percent, performed, prepare, presented, President, profitability, promptly, properly, prospective, prototype, qualitative, quantitative, receipt, record, reduced, Redwood, refusal, register, Regulation, removing, repaid, representation, resale, restated, restating, retrospectively, reviewed, Ronald, Rule, San, Selling, separate, solicitation, sophisticated, specific, step, strike, subsequently, tender, testing, tranche, turn, unconsolidated, unit, voting, William, worth

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BIEI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Premier Biomedical, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2018, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Heidi H. Carl, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: May 23, 2018	By:	/s/ Heidi H. Carl
		Heidi H. Carl
		Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Premier Biomedical, Inc., and will be retained by Premier Biomedical, Inc., and furnished to the Securities and Exchange Commission or its staff upon request.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.